Related references
Note: Only part of the references are listed.Hepatitis B surface antigen: association with sustained response to peginterferon alfa-2a in hepatitis B e antigen-positive patients
Teerha Piratvisuth et al.
HEPATOLOGY INTERNATIONAL (2013)
Serum hepatitis B surface antigen (HBsAg) kinetics in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B
Wai-Kay Seto et al.
HEPATOLOGY INTERNATIONAL (2013)
Decreasing Levels of HBsAg Predict HBsAg Seroclearance in Patients With Inactive Chronic Hepatitis B Virus Infection
Yi-Cheng Chen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Quantification of serum hepatitis B surface antigen: is it useful for the management of chronic hepatitis B?
Harry L. A. Janssen et al.
GUT (2012)
New insight in the pathobiology of hepatitis B virus infection
Maura Dandri et al.
GUT (2012)
Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load
Tai-Chung Tseng et al.
HEPATOLOGY (2012)
A large case-control study on the predictability of hepatitis B surface antigen levels three years before hepatitis B surface antigen seroclearance
Wai-Kay Seto et al.
HEPATOLOGY (2012)
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
Yun-Fan Liaw et al.
HEPATOLOGY INTERNATIONAL (2012)
Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2a
Vincent Rijckborst et al.
JOURNAL OF HEPATOLOGY (2012)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2012)
Serum Hepatitis B Virus-DNA Levels Correlate With Long-term Adverse Outcomes in Spontaneous Hepatitis B e Antigen Seroconverters
Tai-Chung Tseng et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Quantitative Hepatitis B Surface Antigen Levels in Patients With Chronic Hepatitis B After 2 Years of Entecavir Treatment
James Fung et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Recent advances in the treatment of chronic hepatitis B
Chih-Lin Lin et al.
EXPERT OPINION ON PHARMACOTHERAPY (2011)
Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B
E. Jenny Heathcote et al.
GASTROENTEROLOGY (2011)
Quantitative Hepatitis B Surface Antigen and Hepatitis B e Antigen Titers in Prediction of Treatment Response to Entecavir
Jung Min Lee et al.
HEPATOLOGY (2011)
Shorter Durations and Lower Doses of Peginterferon alfa-2a Are Associated with Inferior Hepatitis B e Antigen Seroconversion Rates in Hepatitis B Virus Genotypes B or C
Y. -F. Liaw et al.
HEPATOLOGY (2011)
Kinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavir
Jurrien G. P. Reijnders et al.
JOURNAL OF HEPATOLOGY (2011)
Hepatitis B surface antigen quantification: Why and how to use it in 2011-A core group report
Henry Lik-Yuen Chan et al.
JOURNAL OF HEPATOLOGY (2011)
Viral Determinants of Hepatitis B Surface Antigen Seroclearance in Hepatitis B e Antigen-Negative Chronic Hepatitis B Patients
Henry Lik-Yuen Chan et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score
Hwai-I Yang et al.
LANCET ONCOLOGY (2011)
Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B
Tung-Hung Su et al.
ANTIVIRAL THERAPY (2010)
Hepatitis B surface antigen seroclearance during chronic HBV infection
Chia-Ming Chu et al.
ANTIVIRAL THERAPY (2010)
Hepatitis B e Antigen Seroconversion: A Critical Event in Chronic Hepatitis B Virus Infection
Yun-Fan Liaw et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Carriers of Inactive Hepatitis B Virus Are Still at Risk for Hepatocellular Carcinoma and Liver-Related Death
Jin-De Chen et al.
GASTROENTEROLOGY (2010)
Incidence and Determinants of Spontaneous Hepatitis B Surface Antigen Seroclearance: A Community-Based Follow-up Study
Jessica Liu et al.
GASTROENTEROLOGY (2010)
Hepatitis B Surface Antigen Serum Levels Help to Distinguish Active From Inactive Hepatitis B Virus Genotype D Carriers
Maurizia Rossana Brunetto et al.
GASTROENTEROLOGY (2010)
Age-Specific Prognosis Following Spontaneous Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B
Yi-Cheng Chen et al.
HEPATOLOGY (2010)
Early On-Treatment Prediction of Response to Peginterferon Alfa-2a for HBeAg-Negative Chronic Hepatitis B Using HBsAg and HBV DNA Levels
Vincent Rijckborst et al.
HEPATOLOGY (2010)
A Longitudinal Study on the Natural History of Serum Hepatitis B Surface Antigen Changes in Chronic Hepatitis B
Henry Lik-Yuen Chan et al.
HEPATOLOGY (2010)
Kinetics of Hepatitis B Surface Antigen Decline During 3 Years of Telbivudine Treatment in Hepatitis B e Antigen-Positive Patients
Karsten Wursthorn et al.
HEPATOLOGY (2010)
Nomograms for Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection
Hwai-I Yang et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
HBSAG KINETICS OF DECAY AND BASELINE CHARACTERISTICS OF HBEAG-POSITIVE PATIENTS WITH CHRONIC HEPATITIS B FOLLOWING 3 YEARS OF TENOFOVIR DISOPROXIL FUMARATE (TDF) TREATMENT
E. Gane et al.
JOURNAL OF HEPATOLOGY (2010)
Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: A perspective on Asia
Tin Nguyen et al.
JOURNAL OF HEPATOLOGY (2010)
Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: A European perspective
Jerzy Jaroszewicz et al.
JOURNAL OF HEPATOLOGY (2010)
Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naive HBeAg-positive patients with chronic hepatitis B
R. G. Gish et al.
JOURNAL OF VIRAL HEPATITIS (2010)
Long-term Outcome of Hepatitis B e Antigen-Negative Hepatitis B Surface Antigen Carriers in Relation to Changes of Alanine Aminotransferase Levels Over Time
Dar-In Tai et al.
HEPATOLOGY (2009)
Chronic Hepatitis B: Update 2009
Anna S. F. Lok et al.
HEPATOLOGY (2009)
Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B
Chia-Ming Chu et al.
GASTROENTEROLOGY (2007)
HBsAg seroclearance in asymptomatic carriers of high endemic areas: Appreciably high rates during a long-term follow-up
Chia-Ming Chu et al.
HEPATOLOGY (2007)
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load
UH Iloeje et al.
GASTROENTEROLOGY (2006)
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
CJ Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels
CM Chu et al.
AMERICAN JOURNAL OF MEDICINE (2004)
HBsAg seroclearance in chronic hepatitis B in the Chinese: Virological, histological, and clinical aspects
MF Yuen et al.
HEPATOLOGY (2004)
Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection
YC Chen et al.
GASTROENTEROLOGY (2002)
Global control of hepatitis B virus infection
JH Kao et al.
LANCET INFECTIOUS DISEASES (2002)
Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B
YS Hsu et al.
HEPATOLOGY (2002)
Serologic and clinical outcomes of 1536 Alaska natives chronically infected with hepatitis B virus
BJ McMahon et al.
ANNALS OF INTERNAL MEDICINE (2001)
Share Paper
